Cartesian Therapeutics Earnings
NASDAQ: RNACHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.06+0.235 (+3.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.02
Cartesian Therapeutics earnings summary
Cartesian Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-1.02.
Summary generated from market data by MetaCap's automated system. Methodology